Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 21 June 2002:
Vol. 296. no. 5576, pp. 2172 - 2173
DOI: 10.1126/science.296.5576.2172
Prev | Table of Contents | Next

News

Research on Contraception Still in the Doldrums

Constance Holden

By 2020, about 1.2 billion people, or 16% of the world's population, will be entering their childbearing years. But contraception research hasn't produced a major breakthrough since the introduction of the birth control pill, and there are still only two choices for men: condoms and vasectomy. Most companies have been driven away by liability issues, tough government regulations in the United States and other countries, and concerns about profitability, a big problem for products for which the greatest demand is in poor countries.

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Reversible Immunocontraception in Male Monkeys Immunized with Eppin.
M. G. O'Rand, E. E. Widgren, P. Sivashanmugam, R. T. Richardson, S. H. Hall, F. S. French, C. A. VandeVoort, S. G. Ramachandra, V. Ramesh, and A. Jagannadha Rao (2004)
Science 306, 1189-1190
   Abstract »    Full Text »    PDF »
Reversible infertility in male mice after oral administration of alkylated imino sugars: A nonhormonal approach to male contraception.
A. C. van der Spoel, M. Jeyakumar, T. D. Butters, H. M. Charlton, H. D. Moore, R. A. Dwek, and F. M. Platt (2002)
PNAS 99, 17173-17178
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)